Interferons alpha-2a and beta increase the antitumor activity, detected by MTT assay, of 5-fluorouracil against experimental and clinical human gastrointestinal carcinomas

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 725-728

  Kubota, Tetsuro ^a,b   Kase, Suguru ^a   Otani, Yoshihide ^a   Watanabe, Masahiko ^a   Teramoto, Tatsuo ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b Tokyo Medical and Dental University   (Japan)

Author keywords

5 Fluorouracil; Gastric and carcinoma; Interferon alpha; Interferon beta

Indexed keywords

BETA INTERFERON; FLUOROURACIL; RECOMBINANT ALPHA2A INTERFERON;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; DRUG SYNERGISM; FLUOROURACIL; HUMANS; INTERFERON ALFA-2A; INTERFERON-BETA; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031057187     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ramming KP and Haskell CM: Colorectal malignancies. In: Cancer Treatment (2nd ed.) (Haskell CM ed). Philadelphia, WB Saunders, 1985, pp 295-334.
2. Elias L and Crissman HA: Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: Antiproliferative responses and synergistic interferons with halogenated pyrimidine antimetabolites. Cancer Res 48: 4868-4873, 1988.
3. Wadler S, Wersto R, Weinberg V et al: Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res 50: 5735-5739, 1990.
4. Wadler S and Schwartz EL: Principles in the biomodulation of cytotoxic drugs by interferons. Semin Oncol 19(suppl 3): 45-48, 1992.
5. Grem JL, Chu E, Boarman D et al: Biochemical modulation of fluorouracil with leucovorin and interferon: Preclinical and clinical investigations. Semin Oncol 19(suppl 3): 36-44, 1992.
6. Wadler S: Antineoplastic activity of the combination of 5fluorouracil and interferon: Preclinical and clinical results. Semin Oncol 19(suppl 4): 38-40, 1992.
7. Kase S, Kubota T, Watanabe M et al: Dual modulation by 1-leucovorin and recombinant human interferon alpha 2a of 5-fluorouracil antitumor activity against the human colon carcinoma xenograft Co-4. J Interferon Cytokine Res 15: 1089-1093, 1995.
8. Wadler S, Schwartz EL, Goldman M et al: Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 12: 1769-1775, 1989.
9. Weh HJ, Platz D, Braumann D et al: Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alpha-2b: Preliminary data of a phase II study. Semin Oncol 19(suppl 3): 180-184, 1992.
10. John WL, Neefe JR, Macdonald JS et al: 5-Fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Cancer 72: 3191-3195, 1993.
11. Greenblatt MS, Mangalik A, Ferguson J et al: Phase evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha. Clin Cancer Res 1: 615-620, 1995.
12. Kubota T, Inada T and Ogata Y: Interferon alpha-2a shows antitumor activity in combination with 5-fluorouracil against human colon carcinoma xenografts - a study in reference to thymidylate synthetase activity inhibition -. Jpn J Surg 22: 481-483, 1992.
13. Kubota T, Kurihara N, Kase S et al: The modulating effect of interferon alpha-2a on the antitumor activity of UFT against a human gastric carcinoma xenograft. SC-1-NU, in nude mice. Jpn J Surg 26: 12-14, 1996.
14. Mosmann T: Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65: 55-63, 1983.
15. Shimoyama Y, Kubota T, Watanabe M et al: Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenie assay. J Surg Oneol 41: 12-18, 1989.
16. Suto A, Kubota T, Shimoyama Y et al: MTT assay with reference to the clinical effect of chemotherapy. J Surg Oneol 42: 28-32, 1989.
17. Kubota T, Watanabe M, Asanuma F et al: Experimental study of the clonogenie assay - with reference to the evaluation criteria. Nippon Ganchiryo Gakkaishi (J Jpn Soc Cancer Ther) 20: 744-751, 1985. [in Japanese with English Abstract]
18. Chu E, Zinn S, Boarman D et al: Interaction of interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 50: 5834-5840, 1990.
19. Sehwartz EL, Hoffman M, O'Connor CJ et al: Stimulation of 5-fluorouracil metabolite activation by interferon-alpha in human colon carcinoma cells. Biochem Biophys Res Comm 182: 12321239, 1992.
20. Guglielmi, A. Aschele C, Mori A et al: In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. Clin Cancer Res 1: 1337-1344, 1995.
21. Hill M, Norman A, Cunningham D et al: Royal Marsden phase III trial of fluorouracil with or without interferon alpha-2b in advanced colorectal cancer. J Clin Oncol 13: 1297-1302, 1995.